Evaluation of coronary atherosclerosis on T1WI for preventing future events registry (secondary prevention)

Not Applicable

Recruiting

• Conditions: Ischemic heart disease

• Registration Number: JPRN-UMIN000029246
• Lead Sponsor: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-09-22
• Last Update Posted: 17 October 2023
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with MRI contraindication Patients with chronic kidney disease (stage 4 and 5) or with hemodialysis Patients with pacemaker, implantable cardiodefibrillatior Patients with heart rhythm irregularity (Atrial fibrillation etc) Patients with claustrophobia Patients judged as inappropriate by each researcher

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite of major adverse event (cardiac death, myocardial infarction (3rd universal definition: type1), new ischemia driven coronary revascularization)

Secondary Outcome Measures

Name	Time	Method
All-cause death Cardiac death Cardiovascular death Myocardial infarction/unstable angina New ischemia driven coronary revascularization Occurrence of periprocedural myocardial injury during percutaneous coronary intervention (PCI) (3rd Universal definition type 4). Slow flow phenomenon during PCI.